ArticleFrontiers in oncology2024

IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer.

Lina Somri-Gannam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.